These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21235757)

  • 1. Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs.
    Pascual A; Basco LK; Baret E; Amalvict R; Travers D; Rogier C; Pradines B
    Malar J; 2011 Jan; 10():8. PubMed ID: 21235757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs.
    Fall B; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Wade B; Bercion R; Pradines B
    Malar J; 2011 Oct; 10():310. PubMed ID: 22014157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.
    Pascual A; Parola P; Benoit-Vical F; Simon F; Malvy D; Picot S; Delaunay P; Basset D; Maubon D; Faugère B; Ménard G; Bourgeois N; Oeuvray C; Didillon E; Rogier C; Pradines B
    Malar J; 2012 Feb; 11():45. PubMed ID: 22333675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso.
    Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U
    Malar J; 2015 Jun; 14():251. PubMed ID: 26088768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.
    Diawara S; Madamet M; Kounta MB; Lo G; Wade KA; Nakoulima A; Bercion R; Amalvict R; Gueye MW; Fall B; Diatta B; Pradines B
    Malar J; 2017 Mar; 16(1):118. PubMed ID: 28302108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.
    Quashie NB; Duah NO; Abuaku B; Quaye L; Ayanful-Torgby R; Akwoviah GA; Kweku M; Johnson JD; Lucchi NW; Udhayakumar V; Duplessis C; Kronmann KC; Koram KA
    Malar J; 2013 Dec; 12():450. PubMed ID: 24341604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo.
    Pradines B; Hovette P; Fusai T; Atanda HL; Baret E; Cheval P; Mosnier J; Callec A; Cren J; Amalvict R; Gardair JP; Rogier C
    J Clin Microbiol; 2006 Jul; 44(7):2404-8. PubMed ID: 16825356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum.
    Pradines B; Briolant S; Henry M; Oeuvray C; Baret E; Amalvict R; Didillon E; Rogier C
    Malar J; 2010 Nov; 9():339. PubMed ID: 21108786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.
    Monatrakul P; Mungthin M; Dondorp AM; Krudsood S; Udomsangpetch R; Wilairatana P; White NJ; Chotivanich K
    Malar J; 2010 Nov; 9():326. PubMed ID: 21078202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change.
    Tinto H; Bonkian LN; Nana LA; Yerbanga I; Lingani M; Kazienga A; Valéa I; Sorgho H; Kpoda H; Guiguemdé TR; Ouédraogo JB; Mens PF; Schallig H; D'Alessandro U
    Malar J; 2014 May; 13():207. PubMed ID: 24885950
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Agarwal P; Anvikar AR; Pillai CR; Srivastava K
    Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon.
    Ringwald P; Bickii J; Basco LK
    Am J Trop Med Hyg; 1999 Aug; 61(2):187-92. PubMed ID: 10463665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.
    Chotivanich K; Mungthin M; Ruengweerayuth R; Udomsangpetch R; Dondorp AM; Singhasivanon P; Pukrittayakamee S; White NJ
    Malar J; 2012 May; 11():177. PubMed ID: 22640826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.
    Ndong JM; Atteke C; Aubouy A; Bakary M; Lébibi J; Deloron P
    Trop Med Int Health; 2003 Jan; 8(1):25-9. PubMed ID: 12535246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mimicking febrile temperature and drug stress on malarial development.
    Aunpad R; Somsri S; Na-Bangchang K; Udomsangpetch R; Mungthin M; Adisakwattana P; Chaijaroenkul W
    Ann Clin Microbiol Antimicrob; 2009 Jun; 8():19. PubMed ID: 19523215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire).
    Yavo W; Bla KB; Djaman AJ; Assi SB; Basco LK; Mazabraud A; Koné M
    Afr Health Sci; 2010 Jun; 10(2):111-6. PubMed ID: 21326960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum.
    Childs GE; Häusler B; Milhous W; Chen C; Wimonwattrawatee T; Pooyindee N; Boudreau EF
    Am J Trop Med Hyg; 1988 Jan; 38(1):24-9. PubMed ID: 3277460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.
    Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A
    Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
    Traoré K; Diakité SAS; Bah S; Konaté DS; Dabitao D; Sanogo I; Sangaré M; Dama S; Keita B; Doumbouya M; Guindo MA; Doumbia S; Diakité M
    Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.